Empagliflozin/linagliptin
Empagliflozin/linagliptin was ranked 931st of 1,792 medicines by items in April 2026, with 725 items, down 3.1% on a year earlier.
Dispensed in April 2026
Rolling 12 months
Net ingredient cost · April 2026
Figure 1. Empagliflozin/linagliptin: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to April 2026
Embed this chart
At a glance
- Therapeutic class Drugs used in diabetes
- Presentations 2 shown
- Average cost / item £63.29
- Year on year Down 3.1% on a year earlier
Top presentations, April 2026
The individual products dispensed under Empagliflozin/linagliptin this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Glyxambi 25mg/5mg tablets | 0601023AYBBABAB | 463 | £30,155 |
| Glyxambi 10mg/5mg tablets | 0601023AYBBAAAA | 262 | £15,730 |
Source: NHSBSA Prescription Cost Analysis · to April 2026 OGL v3.0
Where Empagliflozin/linagliptin is dispensed
The regions and dispensing practices with the highest Empagliflozin/linagliptin volumes.
Top regions
Top dispensing practices
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Empagliflozin/linagliptin with
Other medicines in the same BNF section, by prescribing volume.